AssetMark Inc’s Catalyst Pharmaceutical CPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.66M | Sell |
76,640
-6,596
| -8% | -$143K | ﹤0.01% | 807 |
|
|
2025
Q1 | $2.02M | Buy |
83,236
+12,434
| +18% | +$302K | 0.01% | 721 |
|
|
2024
Q4 | $1.48M | Sell |
70,802
-1,443
| -2% | -$30.1K | ﹤0.01% | 775 |
|
|
2024
Q3 | $1.44M | Buy |
72,245
+1,704
| +2% | +$33.9K | ﹤0.01% | 718 |
|
|
2024
Q2 | $1.09M | Buy |
70,541
+1,866
| +3% | +$28.9K | ﹤0.01% | 743 |
|
|
2024
Q1 | $1.09M | Buy |
68,675
+3,997
| +6% | +$63.7K | ﹤0.01% | 713 |
|
|
2023
Q4 | $1.09M | Buy |
64,678
+2,505
| +4% | +$42.1K | ﹤0.01% | 660 |
|
|
2023
Q3 | $727K | Buy |
62,173
+6,218
| +11% | +$72.7K | ﹤0.01% | 685 |
|
|
2023
Q2 | $752K | Sell |
55,955
-2,093
| -4% | -$28.1K | ﹤0.01% | 654 |
|
|
2023
Q1 | $962K | Buy |
58,048
+566
| +1% | +$9.38K | ﹤0.01% | 606 |
|
|
2022
Q4 | $1.07M | Sell |
57,482
-1,650
| -3% | -$30.7K | ﹤0.01% | 555 |
|
|
2022
Q3 | $759K | Buy |
+59,132
| New | +$759K | ﹤0.01% | 578 |
|